Cord Blood America Announces Preferred Pricing for Blue Cross of Northeastern Pennsylvania Members
SANTA MONICA, Calif. and WILKES-BARRE, Pa., Aug. 18 Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today the participation of its subsidiary CorCell Companies, Inc., in the MyHealth Mart Value-Added Discount Program for members of Blue Cross of Northeastern Pennsylvania to access cord blood banking services at a preferred price. The MyHealth Mart Value-Added Discount Program is administered by AllOne Health Management Solutions, Inc. for Blue Cross of Northeastern Pennsylvania.
"Participation in this program allows CorCell to bring the knowledge and awareness of the significant value of storing umbilical cord blood to Blue Cross of Northeastern Pennsylvania members," said Matt Schissler, CorCell's CEO. "We are pleased that we can offer this important life-saving service to their members at a discounted price."
Cord blood stem cells may be used today to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies with many additional uses currently under investigation in clinical trials and in research and development. Previously the umbilical cord, which contains a rich store of stem cells, had been thrown away at birth.
About AllOne Health Management Solutions, Inc.
AllOne Health Management Solutions (HMS) is a national population health management company headquartered in Wilkes-Barre, Pennsylvania. The company offers a comprehensive suite of products and services that helps organizations manage the problem of rising health care costs by empowering individuals to take personal accountability for their health. AllOne Health Management Solutions is part of AllOne Health Group, a company whose affiliates share a common mission: to promote health and wellness, support accessible health care, bring health care costs under control, and improve the productivity and safety of the workforce.
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
Matthew L. Schissler Chairman & CEO Cord Blood America, Inc. 888.882.CORD (2673) for consumer information: www.corcell.com for investor relations: www.cordblood-america.com e-mail: firstname.lastname@example.org
SOURCE Cord Blood America, Inc.
You May Also Like